AN IMPORTANT NOTE: On June 22, 2021, Hadari Oshri –Marc Lubaszka’s business partner– filed a civil harassment restraining order (CHRO) against Investor News reporter Aitana Vargas to stop the publication of her investigative series “A Special Report: The Harrowing Impunity of White-Collar crime,” and any subsequent installments or future media coverage. On August 3, 2021, Vargas filed an anti-SLAPP motion to strike Oshri’s CHRO petition. In a hearing held on September 13, 2021, Los Angeles Superior Court Judge Doreen Boxer granted Vargas’s anti-SLAPP motion and denied Oshri’s civil harassment petition for failure to sustain the applicable burden of proof. Oshri will now have to pay Vargas’s attorney’s fees for filing a frivolous case. The Israeli entrepreneur also declined to go on a recorded interview or provide statements via email. This outlet has striven to reach out to sources to ensure they have the opportunity to provide their own account of events.

Los Angeles (CA) – Aitana Vargas’s exposé “A Special Report: The Harrowing Impunity of White-Collar Crime” last night received one of the LA Press Club’s top journalism awards at a celebrity-packed gala hosted at the Sheraton Universal Hotel that also honored Bill Whitaker’s life achievements.

The judges stated that Vargas’s work is a “compelling story of intrigue and vitriol that goes down a trail through international and domestic law, individual broken dreams, and the hard-fought desire to bring a criminal to justice.”

Speaking after the gala, Vargas said that “this award is a reminder that the victims’ years-long plights and repeated calls for justice have yet to be properly addressed by the justice system.” “This is not over yet.”

Vargas’s tenacity defeated Oshri’s desire to silence the truth

Throughout 2021, Oshri led a months-long campaign aimed at removing any and all media coverage online. The entrepreneur first tried to silence one of the reporter’s sources. Then, in a desperate attempt to stop Vargas’s investigative efforts, the release of documents linking Oshri and Lubaszka to an alleged multi-million dollar PPE scheme, as well as the publication of any and all content, Oshri filed a SLAPP suit against the journalist.

Oshri’s legal efforts against the correspondent came to an abrupt end in September 2021 as a Los Angeles Superior Court judge granted the reporter’s anti-SLAPP motion. During the hearing, the judge called out the entrepreneur for repeatedly interrupting the court proceedings and criticized her attorneys’ failure to provide admissible evidence.

Oshri’s fruitless legal campaign will be costly, for she will have to pay the journalist’s hefty anti-SLAPP legal fees: $23,000.

*Read the notice of ruling on the anti-SLAPP motion here.

Against this backdrop, the in-depth investigative series would have never been released without the tenacity of the author, who was also legally threatened and received a cease-and-desist letter from Oshri’s former attorney, John Tamborelli.

In response to Tamborelli’s 2021 legal threats, the National Writers Union (NWU) sent him a letter demanding that he stop his intimidation campaign towards the reporter.

*Read here the NWU Letter.

Hadari Oshri and Marc Lubaszka forged a partnership based on business and personal misrepresentations

The award-winning story exposes Oshri’s alleged participation in a joint PPE scheme with American broker Marc Lubaszka, who owes nearly $2M to tens of gold IRA investors across the US and has publicly admitted to doing business with Venezuela’s illegal gold mining syndicates.

The pair used Lubaszka’s private jet company, Fly Private X, to sell both nonexistent private jets and PPE during the COVID-19 pandemic, as they ran their operations from a luxurious beachfront property located in East Malibu where they threw parties featuring high-end DJs.

Exclusive documents obtained by Vargas show that Oshri and Lubaszka’s PPE scheme was also linked to convicted COVID-19 fraudster Arael Doolittle.

In the meantime, Oshri founded Trade Safe Pro, LLC, and Lubaszka recruited rapper Dylan Raw to act as his patsy and the VP of Fly Private X. Together, broker and singer founded Buy Gold Brightly to sell gold and IRA plans.

Oshri’s empire: A legacy of business failures

For years, Oshri has misrepresented her “successful” career as a businesswoman by running a strategic online PR campaign that includes the publication of articles written by her ghost writer, Ryan Foland. To this date, she continues to misrepresent her business operations by publishing content on her website and her Medium account.

As if her legacy of demonstrated past business failures were not enough, Oshri has also lost every step of the way in 2021: She lost the anti-SLAPP court battle to Vargas; She’ll have to pay the reporter’s hefty legal fees; The investigative series Oshri tried to stop has been released; Her alleged participation in a multi-million dollar PPE scheme with Marc Lubaszka has been exposed; Two more installments on Oshri’s Xehar wreck (aka fashion fairy project) and Trade Safe Pro, LLC are in the works; And last night, Vargas’s compelling exposé received one of the night’s top LA Press Club journalism awards.

*Read here the full list of winners.

*Since Hadari Oshri filed a meritless case against Investor News contributor Aitana Vargas and had previously declined to provide written comments or go on a recorded interview, it is our policy not to seek further comments from the entrepreneur. Oshri is always welcome to reach out and agree to the proposed interview terms. The same policy applies to her former Counsel, John Tamborelli.

**To contact the newsroom, send an email to info@investornews.io. To contact and send tips to investigative reporter Aitana Vargas, use aitana_investigations@protonmail.com. All malicious emails, phone calls and text messages are reported to law enforcement.

RELATED COVERAGE

Read “Aitana Vargas walks red carpet at tonight’s LA Press Club awards.”

Read “A Special Report: The Harrowing Impunity of White-Collar Crime (Part I): Marc Lubaszka, the ultimate white-collar conman on the run: From a Hollywood Hills mansion to Venezuela’s illegal gold mines and back.” 

Read “A Special Report: The Harrowing Impunity of White-Collar Crime (Part II): Marc Lubaszka’s nonexistent private jets failed to deliver PPE amid the COVID-19 pandemic.”

Read “A Special Report: The Harrowing Impunity of White-Collar Crime (Part III): Pursuing flash money, rapper Dylan Raw partners with conman Marc Lubaszka and becomes his patsy.”

Read “A Special Report: The Harrowing Impunity of White-Collar Crime (Part IV): Hadari Oshri allegedly linked to attempted $370M nonexistent PPE COVID-19 scheme.”

Read 2019 court case against Hadari Oshri exposes her dodgy, aggressive legal maneuvers.

Read Hadari Oshri’s losses mount up as she fails again to silence her victims.

Read Hadari Oshri loses anti-SLAPP court battle against journalist Aitana Vargas.

Read The Legal Bullies Club – The SLAPPers: Featuring Hadari Oshri.

Read Hadari Oshri sued for copyright infringement in 2017.

Read La reportera Aitana Vargas pide 23.000 dólares en honorarios tras pulverizar la querella mordaza de Hadari Oshri.

Read Hadari Oshri deactivates LinkedIn account following PPE exposé.

The post The exposé Hadari Oshri and her attorney tried to stop wins LA Press Club award appeared first on Investor News.

Press release distributed by the SEC.

Featured image: by PeterThoeny is marked with CC BY-NC-SA 2.0.

The post SEC Announces Older Investor Roundtable Virtual Event on April 28 appeared first on Investor News.

The post Check out SEC’s updated list of firms using inaccurate information to solicit investors appeared first on Investor News.

House lawmakers are expected to vote next week on the Marijuana Opportunity, Reinvestment and Expungement, or MORE Act that would remove marijuana from the list of federally controlled substances.

“The MORE Act could be a game changer for USMJ, PURA and PJET,” said Steven Rash, Chairman of ACI Conglomerated and the CEO of USMJ. “Investment and financing of all three companies is complicated by the current federal prohibition of cannabis.  Legalization would open all three companies to new resources that could drive exponential growth.”

USMJ is a cannabis e-commerce company marketing their own, and third-party cannabis-related products. PURA is industrial hemp sector co-op.  PJET is a former cannabis sector company recently shifting into the student life sector but impacted by both its cannabis history and relationship with USMJ and PURA.

Disclaimer:
This News Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any these statements. You are cautioned not to place undue reliance on any those forward-looking statements. Except as otherwise required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements after the date of this news release. None of such forward-looking statements should be regarded as a representation by us or any other person that the objectives and plans set forth in this News Release will be achieved or be executed.

Contact:
ACI Conglomerated
Steven Rash
info@aciconglomerated.com
+1 (800) 861-1350

This is a press release. Click here to see the original story.

Featured image: “marihuana” by Amnesi-a is marked with CC BY-ND 2.0.

The post ACI Optimistic for Growth Potential of USMJ, PURA and PJET from Federal Marijuana Legalization appeared first on Investor News.

Recently the SEC updated its rules to simplify the patchwork of regulations to help companies in fundraising mode. This matters to cannabis companies of all types, especially those that want to utilize the available federal exemptions in their securities offerings.

In the SEC’s own words, “These amendments will promote capital formation and expand investment opportunities while preserving or improving important investor protections.” To hemp and marijuana companies, these changes mean they will have access to a wider pool of prospective investors. These amendments become effective 60 days after publication in the federal register.

The SEC is really taking big strides this fall. I previously wrote about the SEC’s recent expansion of who and what can qualify as an accredited investor. We can expect future refinements to the SEC’s rules to provide more opportunities for investors looking for opportunities and more guidance for companies looking for safe harbors from legal snags when dealing with investors.

The recently updated rules are designed to help startups and more experienced SMEs that have proof of concept in their business models and are in their first or fifth fundraising round. Below are some highlights.

Increased Offering Limits for Regulation A (Reg A), Regulation Crowdfunding (Reg CF), and Rule 504 (Reg D) Offerings.

Under Tier 2 of Regulation A, the maximum offering amount has been increased from $50MM to $75MM, and the maximum offering for secondary sales has been increased from $15MM to $22.5MM.

Under Regulation Crowdfunding, the offering limit has been increased from $1.07MM to $5MM, which will make this option more attractive to some companies where the crowdfunding model makes sense for their business plan. Accredited investors are no longer limited in the amount they can invest under a crowdfunding offering, and non-accredited investors can now use the higher of their annual income or net worth when calculating their investment limits. The financial statement review requirement has been temporarily extended for 18 months in offerings raising $250k or less within a 12-month period.

Offerings utilizing Rule 504 of Reg D can now raise up to $10MM from $5MM, which will increase the use of these already frequently utilized offerings.

Clarified Rules Governing Investment Offering Communications.

Everybody loves demo day, except for companies that have to either have their securities lawyer with them at the table or CEOs who have to continually wink and nod when they say they are not there to sell an investment opportunity in the business. The rule updates mean that issuers can generally talk openly about investment opportunities to “test-the-waters” without those communications being considered “general solicitation” or “general advertising” that make securities lawyers (and a few CEOs) sweat in their sleep.

Clarified Issuer’s Ability to Move from One Exemption to Another: Avoiding Offering Integration.

Boards and executive officers rarely think in terms of “what issuing exemption will we qualify for” when they are determining the criteria for their capital raise. Generally, they are looking at the company’s needs based on the CFO’s analysis, the availability of capital from interested investors and the CEO’s conversations with existing and prospective investors.

These rule amendments fit more with these reality scenarios – that sometimes a company’s offering may qualify for one or two different exemptions – and that the company may need to switch lanes during the offering process. This is often determined long after they have started communicating with prospective investors, soliciting offers, and probably after the company has made its first sale in the offering. Sometimes companies don’t even think about their offering parameters until well after they have received their first investor funds.

Based on a “facts and circumstances” review, the SEC will generally consider offerings as distinct from each other if they have a 30 calendar day window between them. This often matters when one offering utilizes “general solicitation” of prospective investors while the follow-on offering does not.

Offerings relating to employee benefit plans (Rule 701) or offerings by international companies (Reg S) or companies with a registered offering (as opposed to an exempt offering) will not be integrated with other offerings, subject to certain criteria.

Utilization of Special Purpose Vehicles (SPVs).

One reason why crowdfunding has not taken off in hemp and marijuana businesses is because no sane company executive team wants to deal with hundreds or thousands of investors in exchange for a $100 or even a $1,500 investment from each of the investors. They are just not worth the hassle. But the new rule amendments permit the use of certain SPVs for Reg CF and Reg A offerings. This is a boon to cannabis companies, and we may see more crowdfunding offerings by cannabis companies that are willing to deal with a single SPV investment entity as long as someone else deals with the SPV’s investors.

The post SEC’s Investment Rule Updates and Cannabis Fundraising appeared first on Investor News.

The corporate identified for numerous merchandise with cannabinoid and different pure elements launched the non-public placement by way of the DealSquare platform, which is supported by NEO and DealMaker expertise.

DealSquare is an automatic platform that permits capital raisers to launch their non-public placement gives, and buyers to electronically enter a deal. NEO is a bunch of fintech firms that supply capital markets infrastructure, and DealMaker grants the back-office expertise and digital signature providers.

This capital increase is the primary one by way of mixed service choices of DealMaker and DealSquare. MedC Biopharma has created two medication going through medical trials concentrating on Pores and skin T-cell Lymphoma and Cutaneous Leishmaniasis, each of that are thought-about orphan circumstances.

“The launch of our private offering leveraging the joint service capabilities of those respected platforms marks a big step in direction of MedC taking its place amongst trade leaders which are decided to legitimize and ship the well being advantages of cannabinoids to the worldwide neighborhood,” said Dr. Owen Van Cauwenberghe, President of MedC.

“Our tireless efforts and dedication to substantiated medical and well being claims for these merchandise will be certain that their advantages shall be out there to all these in want. We’re lucky to have the ability to make the most of the mixed DealSquare, NEO, and DealMaker providing.”

The corporate famous it plans to make use of the raised capital to help its worldwide growth, first throughout Australia and Canada, and later to achieve Europe, UK, Latin America, and Asia.

Moreover, MedC Biopharma may also broaden its portfolio of merchandise.

The post MedC Biopharma Corporation Launches $3M Private Placement Offering appeared first on Investor News.

The Home voted to move the MORE act on Friday, a chunk of laws that would successfully decriminalize marijuana on a federal degree.

“The US Home of Representatives—the individuals’s home—has taken an enormous step in the direction of science, purpose and justice,” stated to Benzinga hashish activist and entrepreneur Steve DeAngelo.

That is the primary time a hashish legalization invoice was handled in Congress. The invoice will now head in the direction of the Senate, the place outcomes stay unsure.

Most business voices consider that present Republican management of the higher chamber means doom for any cannabis legalization bill. Nevertheless, upcoming Senate runoffs in Georgia may shift the stability of energy within the Senate originally of January, displaying mild on the finish of the tunnel for hashish reform initiatives.

Whereas the passage of the MORE Act by the Home stands as an unprecedented milestone within the historical past of hashish reform, a quantity activists and business individuals have criticized the invoice’s present model for its incapacity to deliver restorative justice to these most affected by hashish prohibition.

What Does the MORE Act Do?

The Marijuana Alternative, Reinvestment, and Expungement (MORE) Act would decriminalize marijuana on the federal degree.

Home Representatives permitted H.R. 3884 with 228 constructive votes, in opposition to 164 detrimental, with 39 abstentions.

“At this time’s vote marks a historic victory for the marijuana coverage reform motion. It signifies that federal lawmakers are lastly listening to the overwhelming majority of People who’re in favor of ending prohibition,” stated Steven Hawkins, government director on the Marijuana Coverage Challenge.

Vice President-elect Kamala Harris sponsored the invoice, which removes marijuana from the listing of scheduled substances and eliminates felony penalties for manufacture, distribution and possession of the plant and its derivatives.

The invoice’s minor provisions embrace the expungement of convictions for federal marijuana-related offenses and a brand new 5% industrial hashish tax poured right into a fund meant to help communities most affected by the Struggle on Medication.

“Hashish by no means belonged within the Managed Substances Act within the first place,” voiced DeAngelo.

Moreover, the MORE act would permit physicians who deal with veterans via the Veterans Affairs well being system to legally advocate medical marijuana.

‘It Falls Quick Of A Good Invoice’

A quantity voices inside the hashish reform motion criticized the MORE Act for not together with sufficient measures to make sure restorative justice is granted to the individuals and communities most affected by the so-called struggle on medicine.

Matt Hawkins, Managing Associate at Entourage Impact Capital, stated that there’s nonetheless loads of work that must be completed with a purpose to ship a real justice reform coverage.

“An modification inserted within the closing days earlier than in the present day’s vote would empower the federal authorities to stop People who’ve been charged with cannabis-related felonies from working within the marijuana business,” says Marijuana Coverage Challenge’s Steven Hawkins.

With this coverage in place, people accused of prior marijuana offenses might be barred from collaborating within the authorized market

“Not solely does this requirement violate each the spirit and intent of this historic laws, it’s strongly at odds with lots of the provisions contained in MORE itself, together with the expungement of information and efforts to take away obstacles from previous convictions,” Steven Hawkins added.

Joe Bayern, President and Incoming CEO of Curaleaf (CSE:CURA) CURLF 5.23%, stated to Benzinga that his firm helps the rules of the MORE Act to create a extra equitable and simply hashish sector. Nevertheless, he added that they “can’t help the language as written within the present invoice, because it punishes social fairness candidates and house owners for prior hashish arrests.”

“That is the antithesis of the unique intent,” he added.

Minorities for Medical Marijuana stated that the group isn’t supporting the MORE Act in its present state.

“The availability that cuts out these with felonies from pursuing companies or work within the business is problematic and is giving us big issues,” stated a spokesperson from the nonprofit to Benzinga.

David Abernathy, VP of Arcview Analysis and Arcview Consulting stated that a number of of the regulatory provisions that had been added on the final minute are regarding and will stifle funding in sure forms of firms.

“That being stated, we’ve assurances from a number of congressional places of work that these provisions shall be mounted in a brand new model of the invoice subsequent 12 months,” he stated.

The post MORE Act Passes House Vote In ‘Giant Step’ For Cannabis Reform, But Falls Short On Restorative Justice appeared first on Investor News.

Jefferies downgrades Aurora stock to hold from buy and says path to profitability is further away than expected.

Aurora Cannabis Inc.’s U.S.-listed shares slid 8% Monday, after the company announced the exit of a key executive, amid insiders selling stakes, dilutive financing moves and questions about the company’s path to profitability.

The Canadian company, which is the most widely held stock ACB, -4.50%ACB, -4.58%  on trading platform Robinhood, said late Saturday that Cam Battley, its chief commercial officer and the man widely viewed as the face of the company, was leaving. Battley had been with Aurora since 2016 and will remain on the board of MedReleaf Australia, a private cannabis company in which Aurora owns a stake.

Jefferies downgraded the stock to hold from buy following the news.

“It is clear to us that the market is lacking conviction in Aurora, and this update will do little to help that,” Jefferies analyst Owen Bennett wrote in a note to clients as he lowered his stock price target to C$3.00 ($2.28) from C$7.00.

Aurora shares have lost 24% of their value in the past month, battered by negative sell-side reports, a controversial convertible bond exchange that was highly dilutive for shareholders and news that Director Jason Dyck had sold more than 1 million of his shares, equal to 57% of his holdings.

But for Bennett, the key issue is one of trust. Aurora has repeatedly failed to meet its own targets and has promised one course of action, before immediately choosing another, he said.

“Key examples are missing revenue guidance despite issuing it after quarter-end at Q4, still little visibility on near-term profitability despite promises since January and throughout 2019 this would happen by Q4, continued dilution (debenture conversion, ATM used) despite reassurances this would not be the case, announcement of ceasing facility constructions just weeks after a press release praising their progression, and most recently the embarrassment of having to freeze sales in Germany over an investigation into the company’s processing methods,” the analyst wrote.

“Against this backdrop, we believe it is easy to make the case that Battley is ‘jumping ship’ with potential further bad news on the way and it is also now one thing too many for our previous conviction.”

MKM analyst Bill Kirk noted it’s the third major management shake-up in the new cannabis sector in a year, coming after Canopy Growth Corp.’s CGC, -0.05%WEED, -4.42%  Bruce Linton was ousted and Aphria Inc.’s APHA, +1.66%APHA, -2.60%  former CEO Vic Neufeld was forced to step down. Battley was one of the strongest voices for the industry, said Kirk.

“The sudden departure, during a period of insider selling, dwindling cash to cover payables, and sector turmoil does not send a strong message to investors,” he wrote, as he cut his stock price target to C$2.00 from C$3.00 and reiterated a sell rating.

Kirk is expecting profitability for cannabis growers to get worse before it gets better, with pricing falling and supply gradually improving. The Canadian sector has had a rocky rollout with red tape hampering the creation of a network of retail stores that has allowed the black market to thrive.

“With legal price gaps widening versus the illicit channel, we believe growth and addressable market opportunities are smaller than others believe,” the analyst wrote. “Further, an outsized (relative to peers) exposure to medical marijuana limits the growth opportunity as most medical markets (Canada, various U.S. states) show flat to declining medical consumption.”

Aurora shares have fallen 59% in 2019, while the ETFMG Alternative Harvest ETF MJ, -0.18%  has declined 30% and the Horizons Marijuana Life Sciences ETF HMMJ, -3.16%  has shed 39% of its value.

The S&P 500 index SPX, +0.00%  has gained 29% and the Dow Jones Industrial Average DJIA, +0.08% has gained 22% in the year to date.

The post Aurora Cannabis stock slammed by executive departure and insiders selling appeared first on Investor News.

The tsunami has all but ended in a defeat for many investors and companies. There is finally good news. The JOBS Act 3.0

The jobs act 1.0 and 2.0 delivered a disruption to investing and helped propel small businesses into multimillion dollar companies.  The great rush of Reg. A and Reg. D and  Equity Crowdfunding seems to have all but halted in the last 2 years for many reasons.

Companies were required to only allow investment form verified  Accredited Investors.  The SEC States An accredited investor is a person that the SEC deems is sophisticated enough to protect themselves in making investment decisions and therefore does not require certain additional protections under certain securities laws.  Currently, to be an accredited investor as an individual, you must (1) earn $200,000 (or $300,000 jointly with your spouse) in income over the last 2 years or (2) $1 million in net worth (excluding home value. There was a major downfall in this strategy, many eligible  Accredited Investors, especially in the US had not verified their status nor had they been given the right material to understand the investments criteria.

Start Up Companies were busy building and marketing their pitch decks and dealing with all the relevant road shows and right things to say. The companies themselves failed to deliver on then best strategy of all to entice investors, and exit strategy.

Indiegogo, Crowdfunder and Start Engine were co-conspirators in a race to entice companies to list on their platforms they did not divulge to the companies that the main strategy investors seek is exits to IPO, Mergers and  Buy Outs.

As with the ICO craze of 2016, many companies made money in marketing and investor relations and many investors did eventually invest only to be dismayed at the lack of forethought in these projects. Over 90% of the ICOs from 2016 are now gone with millions being lost across the board.

While, the JOBS Act gave investors a new avenue and helped companies to deliver an alternative investing vehicle, the accredited investors, were this time left holding the bag.  As more companies were being listed the pool of investors got smaller and less tolerant of mistakes.

In 2014 – 2016 every start up company was the “Uber of ” or was “disrupting some form of economy”, the vast majority of those companies too have run out of funds, or never reached market with their product, even after there was a sizable investment from the members of the equity crowdfunding platforms.

WHAT DOES JOBS ACT 3.0 MEAN FOR COMPANIES?

The JOBS Act 3.0 should be the game changer. This should finally open the doors to investment like never before allowing investors to be accredited by their experience rather than their wealth.

It is now on the companies themselves to deliver solid growth plans and solid ideas. They should have a good team on board who are more than just friends from school and college.  The companies need guidance by seasoned personnel, rather than giving titles out to anyone in the room based on their needs.

The lack of quality education on Equity Crowdfunding and investing is still astonishing in today’s digital age where many  16 year olds had Youtube channels devoted to Crypto.

WHAT IS IN THE FUTURE FOR JOBS ACT 3.0 AND INVESTORS

The JOBS Act 3.0 gives many updates and addendums to the previous 2 JOBS Acts.

The Launch of Venture Exchange is one of the more ambitious and lofty elements, this will no doubt lead to a rush venture exchanges  being brought to market.  It stands to reason, that companies with 10,000 shares should not be regulated equally to those with 10 million shares. The Act 3.0 would allow for the registration of “venture exchanges” with the SEC to provide a venue for small and emerging companies and offer a platform to trade their securities. It would also permit the trading of venture securities, which would apply to early stage companies whose shares are Regulation A+ securities, as well as listed companies whose shares are below the average daily trade volume. The creation of venture exchanges would help even the playing field such that small and startup companies could attract investors.

HOW WILL THIS JOBS ACT 3.0 IMPACT MARIJUANA COMPANIES?

Marijauana and Cannabis companies should be able to utilize some of the many relaxed rules including  the rules for filing confidential IPOs. The current rules permit “an emerging growth company” or any person authorized to act on its behalf file confidentially. The Act 3.0 proposes to change the wording to “an issuer” or any person authorized to act on its behalf. This would widen the pool of companies able to explore confidential filings.

JOBS ACT 3.0 EASING OF REGULATORY BURDENS

The fourth objective of JOBS Act 3.0 is to reduce the economic costs of going public by relaxing the requirements for companies to produce quarterly financial reports. On average, initial regulatory compliance costs more than $1 million in one-time costs associated with an IPO. The Act 3.0 directs the SEC to analyze the costs and benefits of quarterly reports and provide recommendations to Congress for decreasing costs, increasing transparency, and increasing efficiency of quarterly financial reporting. The aim is to allow smaller companies to delay various financial reporting requirements. These tactics would enable more companies to secure an IPO by allowing them to spread the cost over a longer period of time, thus reducing the financial burden of going public.

The Marijuana Industry should be rejoicing and hoping to capitalize on these relaxed regulations along with the recent victory and landmark legalization of marijuana in Illinois just last week. Marijuana, Cannabis and CBD companies now have better access to a larger pool of investors , with less regulation at a critical time for the Cannabis markets.

Accredited Investors can now come for a new class in the investor pool and be self directed. This will help deliver a huge influx of investors into the market and so long as companies have a clear path to exit and solid team this is a win for all.

MARIJUANA INVESTORS SHOULD NOW START LINING UP THEIR PORTFOLIOS FOR 2019-2021

The new acceptance of investment in Cannabis and Marijuana markets as legitimate, of not federally legal yet, is a huge boost for famers, growers and research scientists interested in releasing new medical treatments for Cancer, Addiction, Mood disorders and pain relief.

As more states legalize both in medical marijuana and recreational marijuana use, the older propaganda is not able to out do the merits and positive reports especially from the medical marijuana and CBD research camps.

The older “Reefer Madness” days are slowly fading away as more scientific research points to the legitimate use of these plants and their extracts beyond rolling joints.

The post How The JOBS Act 3.0 should boost Marijuana Investment appeared first on Investor News.

The post Marijuana will be Legal in Illinois appeared first on Investor News.